About Lifecore Biomedical, Inc.
https://www.lifecore.comLifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segments.

CEO
Paul Josephs
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 46
Ratings Snapshot
Rating : D+
Price Target
Institutional Ownership

WYNNEFIELD CAPITAL INC
Shares:4.7M
Value:$37.06M

LEGION PARTNERS ASSET MANAGEMENT, LLC
Shares:4.46M
Value:$35.16M

GREENHAVEN ROAD INVESTMENT MANAGEMENT, L.P.
Shares:3.69M
Value:$29.12M
Summary
Showing Top 3 of 104
About Lifecore Biomedical, Inc.
https://www.lifecore.comLifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segments.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q1-2026 | $31.11M ▼ | $10.86M ▲ | $-9.99M ▼ | -32.12% ▼ | $-0.29 ▼ | $-7.13M ▼ |
| Q4-2025 | $36.44M ▲ | $8.65M ▼ | $-1.15M ▲ | -3.15% ▲ | $-0.06 ▲ | $6.32M ▲ |
| Q3-2025 | $35.15M ▲ | $18.87M ▲ | $-14.77M ▼ | -42.01% ▼ | $-0.47 ▼ | $-7.22M ▼ |
| Q2-2025 | $32.56M ▲ | $13.04M ▼ | $-6.57M ▲ | -20.18% ▲ | $-0.25 ▲ | $981K ▲ |
| Q1-2025 | $24.7M | $16.97M | $-16.23M | -65.7% | $-0.53 | $-8.89M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q1-2026 | $18.86M ▲ | $235.2M ▼ | $198.42M ▼ | $36.79M ▲ |
| Q4-2025 | $8.27M ▲ | $239.34M ▲ | $238.01M ▲ | $1.34M ▼ |
| Q3-2025 | $5.42M ▼ | $237.69M ▼ | $235.46M ▼ | $2.23M ▼ |
| Q2-2025 | $9.46M ▲ | $255.39M ▲ | $239.94M ▼ | $15.45M ▲ |
| Q1-2025 | $5.52M | $246.82M | $250.76M | $-3.94M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q1-2026 | $-9.99M ▼ | $1.76M ▼ | $-1.74M ▲ | $-1.39M ▼ | $-1.36M ▼ | $25K ▼ |
| Q4-2025 | $-1.15M ▲ | $5.35M ▲ | $-2.1M ▼ | $-402K ▲ | $2.85M ▲ | $3.25M ▲ |
| Q3-2025 | $-14.77M ▼ | $1.2M ▲ | $1.54M ▲ | $-6.78M ▼ | $-4.04M ▼ | $-4.26M ▲ |
| Q2-2025 | $-6.57M ▲ | $-6.11M ▼ | $-2.47M ▲ | $12.52M ▲ | $3.94M ▲ | $-8.58M ▼ |
| Q1-2025 | $-16.23M | $-643K | $-3.39M | $1.09M | $-2.94M | $-4.04M |

CEO
Paul Josephs
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 46
Ratings Snapshot
Rating : D+
Price Target
Institutional Ownership

WYNNEFIELD CAPITAL INC
Shares:4.7M
Value:$37.06M

LEGION PARTNERS ASSET MANAGEMENT, LLC
Shares:4.46M
Value:$35.16M

GREENHAVEN ROAD INVESTMENT MANAGEMENT, L.P.
Shares:3.69M
Value:$29.12M
Summary
Showing Top 3 of 104




